Compare ARMP & RGCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ARMP | RGCO |
|---|---|---|
| Founded | N/A | 1912 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Oil & Gas Production |
| Sector | Health Care | Utilities |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 199.7M | 229.4M |
| IPO Year | 1996 | 2005 |
| Metric | ARMP | RGCO |
|---|---|---|
| Price | $5.41 | $21.34 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 2 | 1 |
| Target Price | $15.00 | ★ $22.70 |
| AVG Volume (30 Days) | ★ 93.2K | 11.1K |
| Earning Date | 05-07-2026 | 05-07-2026 |
| Dividend Yield | N/A | ★ 3.93% |
| EPS Growth | N/A | ★ 11.21 |
| EPS | N/A | ★ 1.37 |
| Revenue | N/A | ★ $95,334,212.00 |
| Revenue This Year | N/A | $11.06 |
| Revenue Next Year | N/A | $2.89 |
| P/E Ratio | ★ N/A | $15.75 |
| Revenue Growth | N/A | ★ 12.63 |
| 52 Week Low | $2.86 | $20.55 |
| 52 Week High | $14.98 | $27.17 |
| Indicator | ARMP | RGCO |
|---|---|---|
| Relative Strength Index (RSI) | 55.53 | 41.71 |
| Support Level | $5.12 | $20.87 |
| Resistance Level | $5.63 | $22.36 |
| Average True Range (ATR) | 0.47 | 0.46 |
| MACD | 0.08 | 0.03 |
| Stochastic Oscillator | 84.37 | 16.86 |
Armata Pharmaceuticals Inc is a late clinical-stage biotechnology company focused on the development of high-purity and potent, pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat bacterial infections using proprietary bacteriophage-based technology. It has completed three Phase 2 clinical trials to date. The Company operates and manages its business as one reportable operating segment, which is the business of developing pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat acute and chronic bacterial infections using its proprietary bacteriophage-based technology.
RGC Resources Inc is involved in the business of distribution and sale of natural gas to residential, commercial, and industrial customers within its service territory in Roanoke, Virginia, and its surrounding localities. The company also provides certain non-regulated services. The company relies on multiple interstate pipelines to transport natural gas. The company operates in three segments: Gas Utility, which is the key revenue generator; Investment in Affiliates this segment reflects the income generated through the activities of the Company's investment in MVP and Southgate projects and Parent & Other including the unregulated activities of the Company as well as certain corporate eliminations.